Abstract Submission Deadline: Dec 16, 2025 - Don’t miss out – Early Bird Registration closes on Dec 18, 2025 - Submit your abstract and secure your spot today!

September 14-15, 2026
Renaissance London Heathrow Hotel, London, UK

2nd European Congress on Rare Diseases and Orphan Drugs

Theme : From Innovation to Impact: Transforming Rare Disease Research and Orphan Drug Development

About Euro Rare Diseases 2026

C2P Forum proudly presents the 2nd European Congress on Rare Diseases and Orphan Drugs, set to take place on September14-15, 2026 in London, UK. This two-day event uniting researchers, clinicians, industry leaders, policymakers, and patient advocates from across the globe.

This congress will provide a dynamic platform to explore the latest innovations, challenges, and breakthroughs in rare disease research and orphan drug development. With the aim of fostering collaboration, raising awareness, and accelerating progress, the event will highlight real-world solutions to improve the lives of those affected by rare diseases.

The program will feature keynote lectures, plenary sessions, panel discussions, interactive workshops, and networking opportunities, along with an exhibition showcasing emerging technologies and therapies.

Altogether Euro Rare Diseases is a key event focused on advancing research, encouraging innovation, and enhancing the well-being of people living with rare diseases.

Join us in London for an inspiring gathering that will advance research, strengthen partnerships, and shape the future of rare disease care and global health. Register now to secure your place at this landmark event!

Euro Rare Diseases 2025

Intro Thumbnail

Sessions

Rare Diseases and Orphan Drugs
Orphan Drug Development & Challenges
COVID-Driven Rare Insights
Genetic & Hematologic Rare Disorders
Rare Cancers & Drug Development
Rare Hepatic and Renal Disorders
Newborn Screening & Rare Pediatric Disorders
Rare Endocrine and Neurological Disorders
Approaches to Rare Disease Diagnosis
Novel Therapies for Rare Diseases
Drug Repurposing
Cystic Fibrosis
Cardiovascular & Respiratory Rare Disorders
Biomedical Research
AI in Rare Diseases and Orphan Drugs
Precision and Personalized Medicine
Advances in Rare Disease Research
Rare Skin Diseases
Epidemiology and Disease Control
Biomarker Importance in Rare Diseases
Orphan Drug Pricing and Market Dynamics
Functional Genomics & Gene Therapy for Rare Diseases
Public Health Perspectives in Rare Diseases
Ethical & Regulatory Challenges
Submit Your Abstract

Track Your Abstract

Important Dates

Abstract Submission Deadline: Dec 16, 2025

Early Bird Deadline: Dec 18, 2025

Mid Term Deadline: Feb 27, 2025

Final/Onsite Registration: Sep 14, 2025

Why Attend Conference
  • Stay informed on cutting-edge research, diagnostics, and treatment developments in the rare disease landscape.
  • Enhance your professional practice through expert-led sessions focusing on real-world challenges and innovative solutions.
  • Engage with top researchers, clinicians, industry leaders, patient advocates, and policymakers from around the world.
  • Explore new drug development strategies, targeted therapies, and breakthrough medical technologies.
  • Participate in sessions designed to deepen your understanding of rare disease mechanisms, care models, and regulatory pathways.
  • Present your research or projects and help shape the future direction of rare disease care and orphan drug innovation.
Learning

Gain insights and skills through presentations, workshops, and discussions on cutting-edge research and trends.

Networking

Connect with peers, experts, and collaborators to expand your professional network.

Discuss

Discuss challenges in rare disease treatment, access to orphan drugs, and global strategies for research, development, and fair distribution.

Supported Journals

Where to find us

Venue & Info

Event Venue

Renaissance London Heathrow Hotel, London, UK

Location Address
Bath Rd, Hounslow TW6 2AQ, United Kingdom
View All
Past Conference Report

Euro Rare Diseases 2025

C2P Forum is pleased to announce the successful completion of the European Congress on Rare Diseases and Orphan Drugs, held on November 17-18, 2025, in Rome, Italy.

The conference, themed “Pioneering Care for the Few: Novel Insights into Rare Diseases and Orphan Therapies,” concluded with great success.

We extend our sincere gratitude to the esteemed scientists, distinguished researchers, students and professionals from universities, research institutions, companies, and laboratories worldwide who contributed their latest insights and expertise in the field of Climate change and environmental sustainability.

The conference featured a dynamic program, including keynote addresses, oral presentations, poster sessions, and video presentations. The event was marked by significant engagement and outstanding contributions, and we are delighted to share some of the key highlights presented during the sessions:

  • J Paul Seale, Augusta University, USA
  •  Joan-Lluis Vives Corrons, Josep Carreras Leukaemia Research Institute, Spain
  • Jorge Sales Marques, Hospital Cuf Porto, Portugal
  • Deovrat N Begde, Ambedkar College, India
  • Agata Kulkowska-Gaj, University of Opole, Poland
  • Tiziana Patrizia Cremona, University of Bern, Switzerland
  • Mélissa Bou-Jaoudeh, ProductLife Group, France
  • Sara Dei, University of Verona & University of Naples Parthenope, Italy
  • Shami Pokhrel, Lumbini Medical College, Nepal
  • Tiia Matsi, Addiction Psychiatrist, Finland
  • Soo Hyeon Cho, Korea Disease Control and Prevention Agency (KDCA) & Yonsei University, South Korea
  • Boris Sevarika, University of Basel, Switzerland
  •  Jingzhen Ginger Yang, Nationwide Children’s Hospital, USA
  • Hind Ghannam Alruwaili, King Abdulaziz University, Saudi Arabia
  • Kele Ding, Kent State University & Nationwide Children’s Hospital, USA
  • Osama Alanazi, King Abdulaziz University, Saudi Arabi
  • Mona Mokhtarnejad, Islamic Azad University of Urmia, Iran
  • Arwa M Mahasneh, Queen Mary University of London, UK
  • Margaret A Kadree, Virginia Department of Health, USA
  • Ranko Stevanović, Croatian Society for Harm Reduction in Public Health (HaRPH), Croatia
  • Margarita C Dinamarca, University of Basel, Switzerland
  • Ina Barzel, Erasmus University Medical Center, Netherlands
  • Mariam Ahmed Abu Alim, Yarmouk University, Jordan
  • Jorge Emilio Salazar Flórez, San Martín University Foundation, Colombia
  • Ilaria Svezia, Bambino Gesù Children’s Hospital & University of Rome Tor Vergata, Italy
  • Seyma Akarsu, Istanbul Technical University, Turkey
  • Karin Schmid, Alpha-1 Patient Organization, Switzerland
  • Gulsen Meral, Nisantasi University, Turkey & Epigenetic Coaching, UK
  • Juliana Diniz José, Amazone-se, Brazil
  • Donatella Capone, NAnA ETS, Italy
  • Karin Schmid, Alpha-1 Patient Organization, Switzerland

We would like to express our sincere appreciation to our Session Chairs J Paul Seale, Augusta University, USA, Jorge Sales Marques, Hospital Cuf Porto, Portugal, Gulsen Meral, Nisantasi University, Turkey & Epigenetic Coaching, UK

Building on the success of the Euro Rare Diseases 2025, we are pleased to announce our upcoming event, 2nd European Congress on Rare Diseases and Orphan Drugs on September 14-15, 2026 in London, UK

More info: https://rarediseases.c2pforum.com/

Huge thanks to all the delegates! Your energy and involvement made this event a big success!

Mark your calendars and set your reminders.

Hope to meet you again in London, UK!!